Edition:
United Kingdom

Motif Bio PLC (MTFB.OQ)

MTFB.OQ on NASDAQ Stock Exchange Capital Market

8.42USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$8.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
685
52-wk High
$13.70
52-wk Low
$7.90

Chart for

About

Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on... (more)

Overall

Beta: --
Market Cap(Mil.): £118.90
Shares Outstanding(Mil.): 263.13
Dividend: --
Yield (%): --

Financials

  MTFB.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.28 -- --
ROI: -528.64 1.78 14.61
ROE: -541.44 3.29 16.33

BRIEF-Motif Bio Says 2017 Net Loss Widened To $44.8 Mln

* REPORTED A NET LOSS OF $44.8 MILLION FOR 2017 COMPARED TO A NET LOSS OF $40.3 MILLION IN 2016

10 Apr 2018

BRIEF-Motif Bio Announces Update On NDA Submission For Iclaprim

* ‍CO HAS DECIDED THAT IN ORDER TO ENSURE A COMPLETE AND HIGH QUALITY SUBMISSION, IT WOULD BE PRUDENT TO TAKE ADDITIONAL TIME​

20 Mar 2018

Earnings vs. Estimates